AGP Executive Report
Last update: 9 hours agoClinical Trial Watch: Finnish biotech Aplagon raised €4.8m to expand its antithrombotic programme into a new Phase II trial, targeting vascular access failure in haemodialysis (AVF maturation) and aiming for sustained anti-clot and anti-inflammatory effects at injury sites. Public Health & Care Access: Finland is also pushing a Talent Boost Programme to fill shortages in healthcare and digital roles, including fast-tracking residence permits for skilled workers and families—an approach that could ease pressure on services as the workforce shrinks. Mental Health & Loneliness: New research highlights how loneliness can ease with support tech, with a study finding a small but noticeable reduction in loneliness over three months when older adults used voice assistants, especially with video calling. Cancer Awareness: Tragic reports from the UK describe a young woman who initially thought she had a chest infection but was later diagnosed with lymphoma—an urgent reminder to take persistent symptoms seriously. Emergency Medicine Capacity: Avincis signed for up to 15 more Airbus H145 helicopters to strengthen Helicopter Emergency Medical Services across Europe, including the Nordics.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
